Independent
Tenure on this board
3.0 yrs
Meeting calendar
PEPG · Annual meeting · Thursday, June 18, 2026
Pepgen Inc
3 nominees · 2 ballot items.
Election of three Class I directors (Howard Mayer, Joshua Resnick, Lisa Wyman) and ratification of KPMG LLP as PepGen’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
Market cap
$319M
1Y TSR
-48.5%
Board grade
C
Record date
Apr 21, 2026
Filing
DEF 14A
Meeting concluded · Jun 18, 2026
Follow how the vote landed and what changed on Pepgen Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
Proposals
On the ballot2
- 1
Election of Class I Directors
ManagementBoard: FORElect three Class I directors (Howard Mayer, Joshua Resnick, Lisa Wyman) to serve three-year terms expiring in 2029.
- 2
Ratification of the Appointment of KPMG LLP as Independent Registered Public Accounting Firm for Fiscal Year Ending December 31, 2026
ManagementBoard: FORRatify the audit committee’s appointment of KPMG LLP as PepGen’s independent registered public accounting firm for the 2026 fiscal year.
Director elections
Nominees on the ballot3
Independent
Tenure on this board
4.5 yrs
Also a director at
Sionna Therapeutics Inc (SION)
Independent
Tenure on this board
1.6 yrs
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | 29.0% | 20,064,545 | $36M |
| 2 | Commodore Capital LP | 6.5% | 4,475,000 | $8M |
| 3 | VIKING GLOBAL INVESTORS LP | 5.0% | 3,482,434 | $6M |
| 4 | Laurion Capital Management LP | 4.0% | 2,750,855 | $5M |
| 5 | ADAR1 Capital Management, LLC | 3.7% | 2,591,085 | $5M |
| 6 | Vivo Capital, LLC | 3.4% | 2,325,000 | $4M |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 2.8% | 1,935,920 | $3M |
| 8 | MILLENNIUM MANAGEMENT LLC | 2.6% | 1,786,765 | $3M |
| 9 | RENAISSANCE TECHNOLOGIES LLC | 2.2% | 1,520,246 | $3M |
| 10 | GSA CAPITAL PARTNERS LLP | 1.2% | 852,852 | $2M |
Peers
Nearest market capOther Healthcare sector meetings6
Upcoming shareholder meetings at Pepgen Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Benitec Biopharma IncBNTC
Annual meeting·Dec 3, 2026·$344M
Turn Therapeutics IncTTRX
Annual meeting·Nov 30, 2026·$292M
Galectin Therapeutics IncGALT
Annual meeting·Dec 3, 2026·$349M
Rezolute IncRZLT
Annual meeting·Dec 2, 2026·$374M
Tilray Brands IncTLRY
Annual meeting·Nov 18, 2026·$421M
Accuray IncARAY
Annual meeting·Nov 19, 2026·$456M
Reference
Frequently asked questions
- When is the Pepgen Inc 2026 annual meeting?
- Pepgen Inc (PEPG) holds its 2026 annual shareholder meeting on Thursday, June 18, 2026.
- What is the record date for the Pepgen Inc 2026 meeting?
- The record date for the Pepgen Inc 2026 meeting is Tuesday, April 21, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Pepgen Inc's 2026 meeting?
- The board is presenting 3 director nominees at the Pepgen Inc 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Pepgen Inc 2026 meeting?
- Shareholders will vote on 2 proposals at the Pepgen Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.